Cesar Octavio Castro de la Mora

Mr. Cesar Octavio Castro de la Mora


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2025 in Animals
Verified
Journal Article
Open access
PDF file
Enrique SanhuezaEnrique Sanhueza
Enrique Sanhueza
Cynthia Fernandez-LainezCynthia Fernandez-Lainez
Cynthia Fernandez-Lainez
CMCesar Octavio Castro de la Mora
Cesar Octavio Castro de la Mora
DODANIEL GROUND ORTEGA-ALVAREZ
DANIEL GROUND ORTEGA-ALVAREZ
CMCLAUDIA TERESA MENDOZA
CLAUDIA TERESA MENDOZA
Gabriel López-VelázquezGabriel López-Velázquez
Gabriel López-Velázquez
Exopolysaccharides (EPSs) produced by probiotic bacteria have garnered attention due to their effects on the gut health of humans and animals. The nutrients that probiotics access during their growth are essential for producing beneficial effects on host health. Direct immunomodulatory effects of graminan-type fructans (GTFs) from Agave tequilana through toll-like receptors (TLRs) have been demonstrated. However, the immunomodulatory effects of these fructans, mediated through the EPSs produced by the probiotics cultivated with them, remain unexplored. We explored the immunomodulatory effects of lactic acid bacteria (LAB) strains isolated from swine and their EPSs, based on the GTFs used as carbon sources during their growth. While the LAB strains activated the NF-κB pathway independently of the GTF source, their EPSs activated it in a GTF source-dependent manner. LAB activation through TLR2 showed a GTF source dependency, whereas their EPSs activated TLR2 independently of the GTF source. The LAB and their EPSs activated TLR4 in a GTF source-dependent manner. Both the LAB and their EPSs inhibited the activation of TLR2 and TLR4 agonists, which exhibited a strong dependence on the GTF source. The strength of GTF C’s immunomodulatory effects on LAB illustrates its specificity, its impact on the EPS structure, and its biological effects. Our results support the promising health benefits of this synbiotic model for swine health and lowering inflammation.

Verified
Journal Article
Open access
PDF file
Enrique SanhuezaEnrique Sanhueza
Enrique Sanhueza
NHNatalia Cecilia Hernández-Delgado
Natalia Cecilia Hernández-Delgado
CRCarolina Romo-González
Carolina Romo-González
CMCesar Octavio Castro de la Mora
Cesar Octavio Castro de la Mora
CMCLAUDIA TERESA MENDOZA
CLAUDIA TERESA MENDOZA
Gabriel López-VelázquezGabriel López-Velázquez
Gabriel López-Velázquez
Helicobacter pylori is a Gram-negative bacterium that inhabits the gastric mucosa and infects over 50% of the global population, predominantly in developing countries. The organism causes chronic gastritis and is associated with gastric carcinoma. Traditional antibiotic treatment promotes intestinal dysbiosis and antimicrobial resistance. In this context, postbiotics—the metabolic end products of probiotics—have been shown to be powerful antimicrobial alternatives. The excretion/secretion (E/S) products and exopolysaccharides (EPSs) of lactic acid bacteria (LAB) have been found to exhibit inhibitory activity against pathogens. EPSs are complex sugar polymers involved in biofilm formation and stress resistance, and their activity varies with culture conditions. Most notably, no digestible carbohydrates, such as those present in agave-derived Graminan-Type fructans (GTFs), are effective carbon sources for LAB, which, in turn, affects their metabolic end products. In this study, the E/S products and EPSs of the INP_MX_001 LAB strain were assayed for antimicrobial and antibiofilm activity after growth with three structurally different GTFs. Results indicated potent inhibition of H. pylori survival and biofilm formation in vitro. Our results confirm the promise of using LAB-derived postbiotics, particularly those produced with GTFs, as a novel, non-antibiotic means of combating H. pylori colonization and infection.